DGI:Opportunistische Infektionen/Kryptokokkose/Weiterführende Literatur und Hilfestellungen

1. Nelson M, Dockrell D, Edwards S, et al. British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011. HIV Med. 2011;12 Suppl 2:1-140. doi:10.1111/j.1468-1293.2011.00944_1.x

2. Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America | Clinical Infectious Diseases | Oxford Academic. Accessed November 7, 2021. https://academic.oup.com/cid/article/50/3/291/392360

3. Spec A, Mejia-Chew C, Powderly WG, Cornely OA. EQUAL Cryptococcus Score 2018: A European Confederation of Medical Mycology Score Derived From Current Guidelines to Measure QUALity of Clinical Cryptococcosis Management. Open Forum Infect Dis. 2018;5(11):ofy299. doi:10.1093/ofid/ofy299

4. Guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children. Accessed November 7, 2021. https://www.who.int/publications-detail-redirect/9789241550277

5. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents. :495.

6. Guidelines for the Prevention and Treatment of Opp.pdf. Accessed November 7, 2021. https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/Adult_OI.pdf

7. Tan IL, Smith BR, von Geldern G, Mateen FJ, McArthur JC. HIV-associated opportunistic infections of the CNS. Lancet Neurol. 2012;11(7):605-617. doi:10.1016/S1474-4422(12)70098-4

8. Govender NP, Meintjes G, Mangena P, et al. Southern African HIV Clinicians Society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons: 2019 update. South Afr J HIV Med. 2019;20(1):1030. doi:10.4102/sajhivmed.v20i1.1030